In a mouse model of pancreatic adenocarcinoma (PAAD), Feig C and colleagues found that the depletion of FAP positive cells contributed to improved anti-CTLA-4 or anti-PD-L1 immunotherapy efficacy, revealing the immune suppressive effect of FAP in cancers (14). The gene discussed is CD274; the disease is pancreatic adenocarcinoma.